RVNC Insider Trading

Insider Ownership Percentage: 5.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $143,642.48

Revance Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Revance Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Revance Therapeutics Share Price & Price History

Current Price: $3.08
Price Change: Price Decrease of -0.01 (-0.32%)
As of 12/13/2024 01:00 AM ET

This chart shows the closing price history over time for RVNC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Revance Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/16/2024Erica JordanInsiderSell2,392$3.80$9,089.60114,864View SEC Filing Icon  
3/18/2024Dustin S SjutsPresidentSell9,211$5.04$46,423.44167,550View SEC Filing Icon  
3/18/2024Dwight MoxieInsiderSell8,125$5.04$40,950.00137,815View SEC Filing Icon  
3/18/2024Tobin SchilkeCFOSell9,361$5.04$47,179.44192,666View SEC Filing Icon  
9/5/2023Dwight MoxieSVPSell23,853$17.81$424,821.9355,066View SEC Filing Icon  
8/3/2023Mark J. FoleyCEOSell26,279$22.57$593,117.03840,375View SEC Filing Icon  
7/3/2023Mark J. FoleyCEOSell26,279$24.94$655,398.26866,654View SEC Filing Icon  
7/3/2023Tobin SchilkeCFOSell1,701$25.04$42,593.0479,896View SEC Filing Icon  
6/15/2023Carey Oconnor KolajaDirectorSell2,500$28.24$70,600.0016,561View SEC Filing Icon  
6/9/2023Dustin S SjutsPresidentSell5,000$30.82$154,100.00147,347View SEC Filing Icon  
6/9/2023Mark J. FoleyCEOSell31,279$30.72$960,890.88891,933View SEC Filing Icon  
6/1/2023Tobin SchilkeCFOSell2,701$30.57$82,569.5781,328View SEC Filing Icon  
5/15/2023Dustin S SjutsPresidentSell21,015$34.55$726,068.25152,347View SEC Filing Icon  
5/15/2023Dwight MoxieSVPSell21,401$34.55$739,404.5569,165View SEC Filing Icon  
5/15/2023Mark J. FoleyCEOSell70,447$34.55$2,433,943.85923,212View SEC Filing Icon  
5/1/2023Tobin SchilkeCFOSell3,201$31.70$101,471.7063,081View SEC Filing Icon  
4/3/2023Tobin SchilkeCFOSell3,201$32.15$102,912.1566,282View SEC Filing Icon  
3/9/2023Dustin S SjutsPresidentSell21,508$31.59$679,437.72123,934View SEC Filing Icon  
3/9/2023Dwight MoxieSVPSell18,496$31.59$584,288.6455,547View SEC Filing Icon  
3/9/2023Mark J. FoleyCEOSell70,390$31.59$2,223,620.10823,351View SEC Filing Icon  
3/9/2023Tobin SchilkeCFOSell18,517$31.59$584,952.0373,222View SEC Filing Icon  
3/1/2023Tobin SchilkeCFOSell3,201$33.50$107,233.5049,390View SEC Filing Icon  
2/1/2023Tobin SchilkeCFOSell3,201$34.60$110,754.6054,676View SEC Filing Icon  
1/20/2023Tobin SchilkeCFOSell1,000$31.00$31,000.0057,877View SEC Filing Icon  
1/9/2023Tobin SchilkeCFOSell3,701$27.16$100,519.1658,877View SEC Filing Icon  
9/14/2022Dwight MoxieSVPSell11,000$27.07$297,770.0031,694View SEC Filing Icon  
12/13/2021Angus C. RussellDirectorBuy6,400$15.74$100,736.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Revance Therapeutics (NASDAQ:RVNC)

97.70% of Revance Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RVNC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Revance Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/13/2024Exome Asset Management LLC347,600$1.80M1.2%N/A0.331%Search for SEC Filing on Google Icon
12/3/2024Oddo BHF Asset Management Sas725,000$3.76M0.2%N/A0.691%Search for SEC Filing on Google Icon
11/27/2024Franklin Resources Inc.4,784,658$24.59M0.0%-23.6%4.561%Search for SEC Filing on Google Icon
11/20/2024Virtu Financial LLC23,129$0.12M0.0%N/A0.022%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC2,289,654$11.89M0.0%-0.4%2.183%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd27,381$0.14M0.0%-60.8%0.026%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP446,027$2.32M0.0%N/A0.425%Search for SEC Filing on Google Icon
11/15/2024State Street Corp2,433,963$12.63M0.0%+6.6%2.320%Search for SEC Filing on Google Icon
11/15/2024HighTower Advisors LLC147,400$0.77M0.0%-72.5%0.141%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC699,621$3.63M0.0%-83.7%0.667%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC265,210$1.38M0.0%+11.5%0.253%Search for SEC Filing on Google Icon
11/14/2024Stonepine Capital Management LLC820,000$4.26M2.7%-70.7%0.782%Search for SEC Filing on Google Icon
11/14/2024FORA Capital LLC10,367$54K0.0%N/A0.010%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets24,390$0.13M0.0%-78.8%0.023%Search for SEC Filing on Google Icon
11/13/2024FMR LLC214,596$1.11M0.0%+28.6%0.205%Search for SEC Filing on Google Icon
11/13/2024Dynamic Technology Lab Private Ltd17,001$88K0.0%N/A0.016%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC126,730$0.66M0.0%+1,167.3%0.121%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.790,837$4.10M0.0%+5.5%0.754%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC44,495$0.23M0.0%N/A0.042%Search for SEC Filing on Google Icon
11/8/2024Alpine Associates Management Inc.4,162,861$21.61M1.0%N/A3.971%Search for SEC Filing on Google Icon
11/7/2024LMR Partners LLP2,244,400$11.65M0.1%N/A2.141%Search for SEC Filing on Google Icon
11/6/2024Accredited Investors Inc.12,845$67K0.0%N/A0.012%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP20,819$0.11M0.0%N/A0.020%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC89,825$0.47M0.0%-22.8%0.086%Search for SEC Filing on Google Icon
10/28/2024Rice Hall James & Associates LLC730,190$3.79M0.2%+2.5%0.697%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.20,161$0.11M0.0%+64.3%0.019%Search for SEC Filing on Google Icon
10/11/2024Creative Planning10,858$56K0.0%N/A0.010%Search for SEC Filing on Google Icon
10/10/2024Inspire Investing LLC78,055$0.41M0.0%-43.9%0.074%Search for SEC Filing on Google Icon
10/8/2024Daymark Wealth Partners LLC15,000$78K0.0%-80.3%0.014%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC76,963$0.40M0.0%N/A0.073%Search for SEC Filing on Google Icon
8/21/2024Stonepine Capital Management LLC2,800,000$7.20M6.6%+41.7%2.681%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC10,000$26K0.0%-92.7%0.010%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company42,296$0.11M0.0%+29.4%0.040%Search for SEC Filing on Google Icon
8/15/2024Daymark Wealth Partners LLC76,000$0.20M0.0%+65.2%0.073%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC201,080$0.52M0.0%+567.6%0.192%Search for SEC Filing on Google Icon
8/14/2024Integral Health Asset Management LLC500,000$1.29M0.1%N/A0.477%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC18,157$47K0.0%-17.1%0.017%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.22,167$57K0.0%+52.5%0.021%Search for SEC Filing on Google Icon
8/12/2024Inspire Investing LLC139,079$0.36M0.0%+90.1%0.133%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd69,926$0.18M0.0%+27.9%0.067%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC14,957$38K0.0%N/A0.014%Search for SEC Filing on Google Icon
8/12/2024Blair William & Co. IL290,515$0.75M0.0%-11.8%0.278%Search for SEC Filing on Google Icon
8/12/2024Vanguard Personalized Indexing Management LLC12,659$33K0.0%N/A0.012%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC572,000$1.47M0.0%+53.1%0.548%Search for SEC Filing on Google Icon
8/8/2024Federated Hermes Inc.2,237,505$5.75M0.0%+43.0%2.142%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC712,072$1.83M0.1%-4.6%0.682%Search for SEC Filing on Google Icon
8/6/2024Certuity LLC10,263$26K0.0%N/A0.010%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC116,368$0.30M0.0%+25.2%0.111%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System27,716$71K0.0%+27.6%0.027%Search for SEC Filing on Google Icon
8/2/2024CM Management LLC400,000$1.03M0.9%+60.0%0.383%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers136,347$0.35M0.0%+11.6%0.131%Search for SEC Filing on Google Icon
7/29/2024Zurcher Kantonalbank Zurich Cantonalbank32,961$85K0.0%+47.7%0.032%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp373,015$0.96M0.0%+22.5%0.357%Search for SEC Filing on Google Icon
7/20/2024Nisa Investment Advisors LLC18,911$49K0.0%+2,167.5%0.018%Search for SEC Filing on Google Icon
7/19/2024RF&L Wealth Management LLC48,000$0.12M0.1%+45.5%0.046%Search for SEC Filing on Google Icon
7/13/2024Mirador Capital Partners LP72,355$0.19M0.0%N/A0.069%Search for SEC Filing on Google Icon
7/5/2024DNB Asset Management AS60,229$0.16M0.0%+25.4%0.058%Search for SEC Filing on Google Icon
5/30/2024EULAV Asset Management500,000$2.46M0.1%-20.6%0.479%Search for SEC Filing on Google Icon
5/29/2024Opaleye Management Inc.785,000$3.86M0.8%N/A0.752%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System97,493$0.48M0.0%+9.8%0.093%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD69,361$0.34M0.0%+28.8%0.066%Search for SEC Filing on Google Icon
5/14/2024Capital World Investors13,945,535$68.61M0.0%+16.8%13.351%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC19,906$98K0.1%+109.4%0.019%Search for SEC Filing on Google Icon
5/14/2024CM Management LLC250,000$1.23M1.0%+233.3%0.239%Search for SEC Filing on Google Icon
5/14/2024Natixis79,457$0.39M0.0%N/A0.076%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.5,398,406$26.56M0.0%+6.5%5.180%Search for SEC Filing on Google Icon
5/9/2024Blair William & Co. IL329,267$1.62M0.0%+3.6%0.316%Search for SEC Filing on Google Icon
5/8/2024Inspire Investing LLC73,160$0.36M0.0%+68.1%0.070%Search for SEC Filing on Google Icon
5/7/2024NorthRock Partners LLC30,708$0.15M0.0%N/A0.029%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank194,650$0.96M0.0%+18.2%0.187%Search for SEC Filing on Google Icon
5/3/2024Essex Investment Management Co. LLC220,160$1.08M0.2%+79.8%0.211%Search for SEC Filing on Google Icon
5/3/2024Clarity Capital Partners LLC12,082$59K0.0%N/A0.012%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets211,695$1.04M0.0%+342.1%0.203%Search for SEC Filing on Google Icon
4/30/2024Commonwealth Equity Services LLC108,376$0.53M0.0%-2.5%0.104%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.20,864$0.10M0.0%-92.3%0.020%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.16,981$84K0.0%+67.2%0.016%Search for SEC Filing on Google Icon
4/23/2024Rice Hall James & Associates LLC746,139$3.67M0.2%-1.6%0.716%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC92,918$0.46M0.0%N/A0.089%Search for SEC Filing on Google Icon
3/26/2024HighPoint Advisor Group LLC11,157$98K0.0%N/A0.011%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP449,685$3.95M0.0%-58.5%0.510%Search for SEC Filing on Google Icon
2/26/2024Centaurus Financial Inc.17,612$0.16M0.0%-28.2%0.020%Search for SEC Filing on Google Icon
2/26/2024Virtu Financial LLC24,946$0.22M0.0%-31.4%0.028%Search for SEC Filing on Google Icon
2/22/2024Sierra Summit Advisors LLC86,421$0.76M0.2%N/A0.098%Search for SEC Filing on Google Icon
2/14/2024Nebula Research & Development LLC105,295$0.93M0.3%N/A0.120%Search for SEC Filing on Google Icon
2/14/2024Rubric Capital Management LP1,461,474$12.85M0.3%-8.7%1.664%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC6,823$60K0.0%+626.6%0.008%Search for SEC Filing on Google Icon
2/13/2024Capital World Investors11,939,076$104.94M0.0%-0.2%13.596%Search for SEC Filing on Google Icon
2/13/2024DCF Advisers LLC256,872$2.26M1.2%+869.3%0.293%Search for SEC Filing on Google Icon
2/13/2024Rhenman & Partners Asset Management AB475,872$4.18M0.4%+31.6%0.542%Search for SEC Filing on Google Icon
2/13/2024CIBC Asset Management Inc1,147,294$10.09M0.0%+251.2%1.307%Search for SEC Filing on Google Icon
2/12/2024Capstone Investment Advisors LLC19,449$0.17M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/9/2024Aigen Investment Management LP19,569$0.17M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/9/2024Quest Partners LLC9,532$84K0.0%N/A0.011%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP65,759$0.58M0.0%N/A0.075%Search for SEC Filing on Google Icon
2/9/2024Dynamic Technology Lab Private Ltd27,370$0.24M0.0%N/A0.031%Search for SEC Filing on Google Icon
2/8/2024Great Lakes Advisors LLC233,958$2.06M0.0%+5.3%0.266%Search for SEC Filing on Google Icon
2/8/2024Fairhaven Wealth Management LLC14,859$0.13M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/8/2024Essex Investment Management Co. LLC122,419$1.08M0.2%+46.2%0.139%Search for SEC Filing on Google Icon
2/7/2024Principal Financial Group Inc.269,718$2.37M0.0%-72.0%0.307%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets47,886$0.42M0.0%-66.3%0.055%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Revance Therapeutics logo
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DAXXIFY (DaxibotulinumtoxinA-lanm) for injection for the treatment of glabellar lines and cervical dystonia; has completed phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing OnabotulinumtoxinA, a biosimilar to BOTOX that is in preclinical stage. The company also offers Resilient Hyaluronic Acid (RHA) dermal filler for the correction of moderate to severe dynamic facial wrinkles; and RHA Redensity, a dermal filler for the treatment of moderate to severe dynamic perioral rhytids. It has a collaboration and license agreement with Viatris Inc. to develop, manufacture, and commercialize onabotulinumtoxinA. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Read More on Revance Therapeutics

Today's Range

Now: $3.08
Low: $3.08
High: $3.11

50 Day Range

MA: $4.60
Low: $3.03
High: $5.92

52 Week Range

Now: $3.08
Low: $2.30
High: $9.74

Volume

3,570,442 shs

Average Volume

2,809,723 shs

Market Capitalization

$323.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.81

Who are the company insiders with the largest holdings of Revance Therapeutics?

Revance Therapeutics' top insider investors include:
  1. Mark J Foley (CEO)
  2. Tobin Schilke (CFO)
  3. Dustin S Sjuts (President)
  4. Dwight Moxie (Insider)
  5. Erica Jordan (Insider)
  6. Dwight Moxie (SVP)
  7. Carey Oconnor Kolaja (Director)
Learn More about top insider investors at Revance Therapeutics.

Who are the major institutional investors of Revance Therapeutics?

Revance Therapeutics' top institutional investors include:
  1. Franklin Resources Inc. — 4.56%
  2. Alpine Associates Management Inc. — 3.97%
  3. State Street Corp — 2.32%
  4. Geode Capital Management LLC — 2.18%
  5. LMR Partners LLP — 2.14%
  6. Stonepine Capital Management LLC — 0.78%
Learn More about top institutional investors of Revance Therapeutics stock.

Which major investors are selling Revance Therapeutics stock?

During the last quarter, RVNC stock was sold by these institutional investors:
  1. Walleye Capital LLC
  2. Stonepine Capital Management LLC
  3. Franklin Resources Inc.
  4. HighTower Advisors LLC
  5. BNP Paribas Financial Markets
  6. Inspire Investing LLC
  7. Daymark Wealth Partners LLC
  8. XTX Topco Ltd
Within the previous year, company insiders that have sold Revance Therapeutics company stock include:
  1. Mark J Foley (CEO)
  2. Tobin Schilke (CFO)
  3. Dustin S Sjuts (President)
  4. Dwight Moxie (Insider)
Learn More investors selling Revance Therapeutics stock.

Which major investors are buying Revance Therapeutics stock?

Within the last quarter, RVNC stock was purchased by institutional investors including:
  1. Alpine Associates Management Inc.
  2. LMR Partners LLP
  3. Oddo BHF Asset Management Sas
  4. Wellington Management Group LLP
  5. Exome Asset Management LLC
  6. State Street Corp
  7. Algert Global LLC
  8. Polar Asset Management Partners Inc.